Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 17,737-17,748 of 23,847
Drug study icon
CompletedNCT02230384

Novel Smoking Cessation Drug for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 66 Years
Countries
United States
Sponsor
K.N. Roy Chengappa
Condition
Schizophrenia
Device study icon
Enrolling By InvitationNCT07369180

NQ Square TMS for MDD 1Dx3S Adults Multi-site Sham-controlled Protocol

This study is comparing Active Accelerated rTMS Treatment with Sham Accelerated Protocol for people with depression. Participants receive Active Accelerated rTMS Treatment or Sham Accelerated Protocol and complete study visits and assessments.

Multiple locations, including Campbell
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 85 Years
Countries
United States
Sponsor
NeuroQore Inc.
Condition
Depression
Drug study icon
CompletedNCT03395392

NRX-101 for Depression in bipolarity With Subacute Suicide prevention

This study exists to explore whether the medication NRX-101 could improve care and understanding. Researchers are trying to understand whether the medication NRX-101 can better prevent setbacks and support longer-term stability.

Multiple locations, including Culver City
Bipolarity, Depression, ...DrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
NeuroRx, Inc.
Condition
Bipolarity, Depression, ...
Drug study icon
WithdrawnNCT02603458

NRX-1074 in Early Course Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Boston
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
Drug study icon
CompletedNCT03402152

NRX101 Glx Biomarker Validation Study

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

In New York
Suicidality, Bipolarity, ...DrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
NeuroRx, Inc.
Condition
Suicidality, Bipolarity, ...
Behavioral study icon
CompletedNCT06653829

NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

In Rochester
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
North Shore Therapeutics, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.